Norwalk Vaccine Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 4, 2009

Primary Completion Date

April 7, 2010

Study Completion Date

August 18, 2010

Conditions
Acute GastroenteritisNorwalk Virus Infection
Interventions
BIOLOGICAL

Norwalk VLP vaccine

Norwalk VLP vaccine dry powder

BIOLOGICAL

mannitol and sucrose

Mannitol and sucrose as placebo-matching Norwalk VLP Vaccine dry powder

BIOLOGICAL

Norwalk virus

Norwalk virus solution

Trial Locations (3)

21201

SNBL, Baltimore

45206

Cincinnati Childrens Hospital Medical Center, Cincinnati

77030-3498

Baylor College of Medicine, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT00973284 - Norwalk Vaccine Study | Biotech Hunter | Biotech Hunter